National Center for Complementary and Integrative Health (NCCIH)

NIH…Turning Discovery Into Health

Follow NCCIH Subscribe to our email update Subscribe to the NCCIH RSS feed Follow NCCIH on FacebookRead our disclaimer about external links Follow NCCIH on TwitterRead our disclaimer about external links


NCCAM Announces Complementary and Alternative Medicine and Oncology Fellowship

For Immediate Release:

Monday, May 9, 2005


NCCAM Press Office, 301-496-7790

This page is an historical document and contains content that may be out of date.


The National Center for Complementary and Alternative Medicine (NCCAM), the National Cancer Institute (NCI), and the Food and Drug Administration’s Center for Drug Evaluation and Research have created a unique 3-year fellowship for new researchers to gain expertise in complementary and alternative medicine (CAM) and cancer.


CAM approaches are increasingly being used by people with cancer and their practitioners to address medical, psychosocial, and spiritual needs. Medical oncologists are frequently asked for their opinion on the use, benefits, and risks of CAM practices in the treatment of cancer. Because of the high use of CAM by cancer patients, more basic and clinical research is needed.

Fellows will be trained both in medical oncology and CAM and will be exposed to clinical and regulatory aspects unique to this field.


Eligible candidates are oncology fellows at NCI or at another accredited fellowship program in the U.S., who are completing their first clinical year.

For more information, visit or contact the NCCAM/NCI Fellowship Coordinator Patrick Mansky, M.D. via telephone at 301-435-6760 or via e-mail at

The National Center for Complementary and Integrative Health's mission is to define, through rigorous scientific investigation, the usefulness and safety of complementary and integrative health approaches and their roles in improving health and health care. For additional information, call NCCIH’s Clearinghouse toll free at 1-888-644-6226. Follow us on Twitter, Facebook, and YouTube.